Inotiv

C57BL/6 Diet-induced obesity (DIO) mice

C57BL/6NHsd DIO Control
Location
Order Today
+1 800 793 7287 Online order  

Order code: 044

Description
Health monitoring reports
Pricing
Technical resources

  • Coat: Black
  • Haplotype: H-2b
  • Litter Average: 5.0
  • Normal phenotype
  • High preference for alcohol
  • Microphthalmia
  • Incidence of hydrocephalous
  • The C57BL/6N subline carries a retinal degeneration 8 mutation (rd8)
  • The C57BL/6NHsd subline does not carry the Nnt (nicotinamide nucleotice transhydrogenase) gene deletion

 

Origin:
C57BL/6NHsd; Derived from a nucleus colony obtained from the National Institutes of Health, Bethesda, Maryland.

 

Diet and Husbandry:
Our rodent models are raised and maintained on the following diet, bedding, and enrichment products:

 

Model Support Services:
Inotiv offers related model support services to deliver research-ready models to your facility:

Available regions:


Order code: 044 - US
Description Price Currency
6-7 weeks n/a USD
7-8 weeks 44.25 USD
8-9 weeks 49.00 USD
9-10 weeks 54.65 USD
10-11 weeks 65.55 USD
11-12 weeks 71.75 USD
12-13 weeks 77.95 USD
13-14 weeks 84.15 USD
14-15 weeks 90.35 USD
15-16 weeks 96.55 USD
16-17 weeks 102.75 USD
17-18 weeks 108.95 USD
18-19 weeks 115.15 USD
19-20 weeks 121.35 USD
20-21 weeks 127.55 USD
21-22 weeks 133.75 USD
22-23 weeks 139.95 USD
Research use and related publications
  • Diet-induced obesity
  • Metabolic disease
  • Inflammatory disease
  • Cardiovascular disease
  • Pre-diabetes
  • Liver disease

2025 Product guide

Receive a copy of our current research models and services product guide.

Download today  
SCIENCE Surgeon - clinical

SCIENTIFIC

INSIGHTS

Keep up-to-date with the latest industry thinking and scientific insights

Explore today
90-anni-globe-widget

More than 90 years of working together, to build a healthier and safer world

Explore our history
Decoration

Subscribe to updates from Inotiv

Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.
Subscribe now